Effectiveness of atypical antipsychotics for substance use in schizophrenia patients
Authors:
- Jeffrey SwansonJSJeffrey Swanson
- Richard A. Van DornRDRichard A. Van Dorn
- Marvin S. SwartzMSMarvin S. Swartz
- 25 June 2007
- journal article
- research article
- Published by Elsevier in Schizophrenia Research
- Vol. 94 (1-3) , 114-118
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Substance Use in Persons With Schizophrenia: Baseline Prevalence and Correlates From the NIMH CATIE StudyYearbook of Psychiatry and Applied Mental Health, 2007
- Atypical Antipsychotic Medication and Substance Use‐Related Outcomes in the Treatment of SchizophreniaThe American Journal on Addictions, 2006
- One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophreniaSchizophrenia Research, 2006
- The effects of early sexual abuse on adult risky sexual behaviors among persons with severe mental illnessChild Abuse & Neglect, 2005
- Clozapine, quetiapine and olanzapine among addicted schizophrenic patients: towards testable hypothesesInternational Clinical Psychopharmacology, 2003
- Can Risperidone Reduce Cocaine Use in Substance Abusing Schizophrenic Patients?Journal of Clinical Psychopharmacology, 2002
- Recent victimization in women and men with severe mental illness: Prevalence and correlatesJournal of Traumatic Stress, 2001
- Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patientsSchizophrenia Research, 1999
- Substance use: a powerful predictor of relapse in schizophreniaSchizophrenia Research, 1996
- Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) StudyJAMA, 1990